BerandaBEAM • NASDAQ
add
Beam Therapeutics Inc
Tutup sebelumnya
$27,82
Rentang hari
$27,46 - $28,00
Rentang tahun
$13,53 - $35,25
Kapitalisasi pasar
2,81 M USD
Volume Rata-Rata
1,75 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 9,70 jt | -32,03% |
Biaya operasional | 26,74 jt | 0,85% |
Penghasilan bersih | -112,73 jt | -16,61% |
Margin laba bersih | -1,16 rb | -71,58% |
Penghasilan per saham | -1,10 | 5,98% |
EBITDA | -121,25 jt | -20,02% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,07 M | 16,12% |
Total aset | 1,31 M | 11,93% |
Total liabilitas | 345,08 jt | -9,20% |
Total ekuitas | 966,00 jt | — |
Saham yang beredar | 98,69 jt | — |
Harga terhadap nilai buku | 2,84 | — |
Tingkat pengembalian aset | -23,46% | — |
Tingkat pengembalian modal | -27,34% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -112,73 jt | -16,61% |
Kas dari operasi | -81,48 jt | 7,54% |
Kas dari investasi | 65,66 jt | 165,83% |
Kas dari pembiayaan | 1,68 jt | 32,73% |
Perubahan kas bersih | -14,15 jt | 77,24% |
Arus kas bebas | -45,72 jt | -6,34% |
Tentang
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
CEO
Didirikan
2017
Situs
Karyawan
510
